Bellerophon Therapeutics, Inc.: cash_and_equivalents
| Value | {"amount": 14202000, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"} |
|---|---|
| Period | (as of 2016-12-31) |
| Status | current |
| Entity | Bellerophon Therapeutics, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T16:22:44.668338+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/adeb0e4c-79c7-4aec-b360-571a623fc0bc
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001600132-18-000034 · Open the official SEC filing →Retrieved: 2026-08-19T16:22:44.668338+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001600132/cash-and-equivalents/2016-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/adeb0e4c-79c7-4aec-b360-571a623fc0bc
History
- supersedes {"amount": 14453000, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"} (evidence 0001600132-17-000006)